CCCC
Price
$2.26
Change
-$0.03 (-1.31%)
Updated
Jul 25 closing price
Capitalization
160.48M
10 days until earnings call
GBIO
Price
$4.61
Change
+$0.41 (+9.76%)
Updated
Jul 25 closing price
Capitalization
30.89M
10 days until earnings call
Interact to see
Advertisement

CCCC vs GBIO

Header iconCCCC vs GBIO Comparison
Open Charts CCCC vs GBIOBanner chart's image
C4 Therapeutics
Price$2.26
Change-$0.03 (-1.31%)
Volume$570.53K
Capitalization160.48M
Generation Bio
Price$4.61
Change+$0.41 (+9.76%)
Volume$181.22K
Capitalization30.89M
CCCC vs GBIO Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. GBIO commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and GBIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CCCC: $2.26 vs. GBIO: $4.61)
Brand notoriety: CCCC and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 41% vs. GBIO: 130%
Market capitalization -- CCCC: $160.48M vs. GBIO: $30.89M
CCCC [@Biotechnology] is valued at $160.48M. GBIO’s [@Biotechnology] market capitalization is $30.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 6 TA indicator(s) are bullish while GBIO’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 6 bullish, 4 bearish.
  • GBIO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -2.59% price change this week, while GBIO (@Biotechnology) price change was +13.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

GBIO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($160M) has a higher market cap than GBIO($30.9M). CCCC YTD gains are higher at: -37.222 vs. GBIO (-56.509). GBIO has higher annual earnings (EBITDA): -69.2M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. GBIO (46.7M). CCCC has less debt than GBIO: CCCC (64.4M) vs GBIO (87.6M). CCCC has higher revenues than GBIO: CCCC (39.8M) vs GBIO (24.6M).
CCCCGBIOCCCC / GBIO
Capitalization160M30.9M518%
EBITDA-102.74M-69.2M148%
Gain YTD-37.222-56.50966%
P/E RatioN/AN/A-
Revenue39.8M24.6M162%
Total Cash215M46.7M460%
Total Debt64.4M87.6M74%
TECHNICAL ANALYSIS
Technical Analysis
CCCCGBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BWAGF126.28N/A
N/A
BAWAG Group AG
GWTR0.03N/A
N/A
Global Water Technologies, Inc.
OBSJF0.35N/A
N/A
Obrascon Huarte Lain Brasil S.A.
VONOY16.14-0.24
-1.47%
VONOVIA SE
TMGEF0.12N/A
-1.66%
Thermal Energy International Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.31%
BEAM - CCCC
54%
Loosely correlated
+3.68%
CRBU - CCCC
51%
Loosely correlated
-3.80%
PRME - CCCC
51%
Loosely correlated
-3.22%
IDYA - CCCC
50%
Loosely correlated
-1.33%
KYMR - CCCC
50%
Loosely correlated
-0.13%
More